HOME >> BIOLOGY >> NEWS
New way found to see light through novel protein identified by Dartmouth geneticists

Hanover, NH--Dartmouth Medical School geneticists have discovered a new class of proteins that see light, revealing a previously unknown system for how light works.

The novel photoreceptors are part of the gears that drive biological clocks, the cellular timekeepers of the circadian rhythm, which paces life's daily ebb and flow in a 24-hour light-dark cycle. Their identification also opens a window for genetically engineered drug delivery systems that exploit the properties of these newfound molecules.

The findings, by Drs. Jay Dunlap and Jennifer Loros, and graduate student Allan Froehlich, will be published in an upcoming issue of Science; they are currently reported online in Science Express.

Dunlap, professor and chair of genetics, and Loros, professor of biochemistry, were the first to delineate circadian clockwork in Neurospora, the common bread mold and one of the best-known genetic model systems. They pieced together how the circadian cycle works and demonstrated how light resets it through a complex of interwoven molecular messages.

"That left open the question then of what actually absorbed the light. What we found is a new paradigm within clocks," Dunlap says. "Light is absorbed by a molecule that is actually within the clock and is an activating element in the clock cycle. This is a new molecular mechanism to see light and a new way for light to have an effect. Although the protein has been known for sometime, this is a configuration of activities that's not been reported before for any protein."

Since bread mold belongs to the fungal phylogenetic kingdom, eventually researchers may be able to harness the proteins against fungal disease. "Virtually nothing is known about how pathogenic fungi respond to light or whether that can be exploited for a noninvasive therapy," Dunlap acknowledges. It may be a long shot, but drug therapies start with properties people don't have. "If you want to do therapy--antifu
'"/>

Contact: DMS Communications
dms.communications@dartmouth.edu
603-650-1492
Dartmouth Medical School
4-Jul-2002


Page: 1 2

Related biology news :

1. New signs of life found at the Poles
2. Key cell-death step found
3. European common frog found to use novel mating strategy
4. Byproduct of water-disinfection process found to be highly toxic
5. Genuine stem cells found in skin might treat hair loss, wounds
6. Flame retardants found on supermarket shelves
7. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
8. Genetic clues found for common congenital brain disorder
9. New clues to hereditary blinding disease found
10. Anti-bacterial additive found in Maryland streams
11. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2018)... ... October 03, 2018 , ... Fit4D, ... the appointment of healthcare visionary, Jimmy Lee, as Strategic Advisor to the company’s ... of healthcare industry experience. As a Senior Executive at Anthem, he had P&L ...
(Date:10/2/2018)... ... ... a fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite thing in the world ... much that whenever anyone comes to our door, he grabs a toy to greet them, ... 2017, Stuart began limping and eventually could no longer play fetch. Though he was ...
(Date:10/2/2018)... ... October 02, 2018 , ... As a leading ... Biosciences, The Cell Analysis Company , is excited to offer xCELLigence® RTCA ... design and data analysis for immune oncology researchers are now much easier, especially ...
Breaking Biology News(10 mins):
(Date:9/29/2018)... ... September 29, 2018 , ... Voxx ... early-stage companies to access the power of influence analytics and data-driven engagement decision ... a broader market that didn’t necessarily have access to the same financial resources ...
(Date:9/27/2018)... ... 2018 , ... Medable was named DPharm Idol at this ... human digitome, a digital representation of human health and disease, by removing the ... data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained that their ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform with Flagship’s ... to empower clinical trials in the immuno-oncology (IO) space. , IO therapies ...
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, James ... would have gotten in medicine, if we didn’t have the means to measure the ... patients?” His answer, “Nowhere! And that is what’s holding up progress in stem ...
Breaking Biology Technology:
Cached News: